Company: EOI
Filing Date: 2025-01-22
Form Type: 424B5
Source: 0001193125-25-010284
Chunk: 0

Company: Eaton Vance Enhanced Equity Income Fund
Filing Date: 2025-01-22
Form: 424B5
Chunk 0
---
Filed pursuant to Rule 424(b)(5)
File No. 333-284330 Prospectus Supplement (To Prospectus dated January 17, 2025) Eaton Vance Enhanced Equity Income Fund Up to 6,116,344 Common Shares Eaton Vance Enhanced Equity Income Fund (the “Fund,” “we,” or “our”) is a diversified, closed-endmanagement investment company that commencedoperations on October 29, 2004. Our primary investment objective is to provide current income, with a secondary objective of capital appreciation. The Fund pursues its investment objectives by investing primarily in a portfolio of mid-and large-capitalization common stocks. The Fund has entered into a distribution agreement dated January 22, 2025 (the “Distribution Agreement”) with Eaton Vance Distributors, Inc. (the “Distributor”) relating to the common shares of beneficial interest (the “Common Shares”) offered by this Prospectus Supplement dated January 22, 2025 and the accompanying Prospectus dated January 17, 2025. The Distributor has entered into a dealer agreement, dated January 22, 2025, (the “Dealer Agreement”) with UBS Securities LLC (the “Dealer”) with respect to the Fund relating to the Common Shares offered by this Prospectus Supplement and the accompanying Prospectus. In accordance with the terms of the Dealer Agreement, we may offer and sell up to 6,116,344 Common Shares, $0.01 par value per share, from time to time through the Dealer as sub-placementagent for the offer and sale of the Common Shares. Under the Investment Company Act of 1940, as amended (the “1940 Act”), the Fund may not sell any Common Shares at a price below the current net asset value of such Common Shares, exclusive of any distributing commission or discount. Our Common Shares are listed on the New York Stock Exchange (“NYSE”) under the symbol “EOI.” As of January 13, 2025, the last reported sale price for our Common Shares on the NYSE was $20.34 per share. Sales of our Common Shares, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” as defined in Rule 415 under the Securities Act of 1933, as amended (the “1933 Act”), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange. The Fund will compensate the Distributor